DarioHealth Corp. (NasdaqCM:DRIO) announced a private placement of up to 1,821,437 common shares at a price of $2.80 per share for gross proceeds of $5,100,024 on January 9, 2017. The company also issue warrants to purchase 1,821,437 of common shares at an exercise price of $3.5 per share. The warrants will be exercisable after the six month anniversary of each respective closing and will expire on the five years anniversary of their issuance. The company will issue securities pursuant to exemption provided under Regulation D and Regulation S. On same date, the company has issued 1,113,922 shares for gross proceeds of $3,174,677.7 in its first tranche. The transaction was led by new investor OurCrowd Qure, a fund managed by OurCrowd Ltd. along with participation from existing investors. OurCrowd Ltd. invested $2,500,000 in the transaction and received 2 board seats. The company has also issued 1,113,922 warrants to investors.